Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds.
Fujiki
H
H
Cancer Prevention Division, National Cancer Center Research Institute, Tokyo, Japan.
Suganuma
M
M
D000818:Animals; D000935:Antifungal Agents / Q000633:toxicity; D002273:Carcinogens / Q000633:toxicity*; D004988:Ethers, Cyclic / Q000633:toxicity*; D006801:Humans; D052998:Microcystins; D009369:Neoplasms / Q000139:chemically induced; D019319:Okadaic Acid; D010456:Peptides, Cyclic / Q000633:toxicity; D010749:Phosphoprotein Phosphatases / Q000037:antagonists & inhibitors*; D011714:Pyrans; D013141:Spiro Compounds; D013329:Structure-Activity Relationship
D000935:Antifungal Agents; D002273:Carcinogens; D004988:Ethers, Cyclic; D052998:Microcystins; D010456:Peptides, Cyclic; D011714:Pyrans; D013141:Spiro Compounds; C053079:tautomycin; D019319:Okadaic Acid; C078588:microcystin; D010749:Phosphoprotein Phosphatases